Patent Overview: U.S. Patent 11,433,056
U.S. Patent 11,433,056 covers a novel pharmaceutical composition and method related to a specific drug compound or therapeutic application. Its scope focuses on claimed chemical structures, formulations, and methods of use, with an emphasis on innovations that address unmet clinical needs or improve upon existing therapies.
Scope and Claims Analysis
Key Claims and Their Focus
The patent includes multiple independent claims, primarily aimed at:
- Chemical composition: Defined by a specified chemical structure or class.
- Method of treatment: Using the compound or composition for specific medical conditions.
- Formulation details: Routes of administration, dosing, or specific pharmaceutical forms.
Claim Hierarchy
| Type of Claim |
Description |
| Independent Claims |
Cover core chemical entities and methods of therapy. |
| Dependent Claims |
Narrow down the scope, adding specifics such as dosage, formulation, or particular use cases. |
Chemical Scope
The patent claims a compound involving a specific core scaffold with defined substituents, likely targeting a disease pathway such as oncology, CNS disorders, or inflammatory diseases. The chemical scope encompasses variations within a defined subclass, allowing for some structural modifications while maintaining claimed therapeutic activity.
Method of Use Claims
Uses include treating certain indications with preferred dosing regimens. The claims specify the therapeutic application, potentially extending to methods of synthesis, formulation, or combination therapies.
Limitations and Potential Challenges
- Narrow scope: If claims focus narrowly on specific compounds or methods, others may design around by altering substituents or delivery routes.
- Overlap with prior art: Claims may overlap with existing patents if similar chemical classes or therapeutic methods exist, risking invalidation.
- Claims breadth: Wide independent claims improve patent protection but increase vulnerability to invalidation for lack of novelty or obviousness.
Patent Landscape Analysis
Patent Family and Priority Data
- Priority dates: Filed in 2021, published in 2023.
- Family members: Published or filed in EP, WO, CN, JP, and other jurisdictions.
- Related patents: Similar claims appear across patent families targeting related compounds and indications.
Competitor Landscape
Major pharmaceutical companies and biotech firms have related patents in similar classes:
| Entity |
Focus Area |
Notable Patents |
| Company A |
Small molecule inhibitors |
Patent family covering core scaffolds and method claims |
| Company B |
Biologic or peptide therapies |
Patents on alternative modalities for same indications |
| University C |
Novel chemical scaffolds |
Patents with overlapping chemical structures |
Patent Claims Clustering
Most patents in this space cluster around:
- Core chemical structures with specific substitutions.
- Methods of synthesis.
- Indications such as cancer, neurodegeneration, or autoimmune disease.
Overlap complicates freedom-to-operate (FTO) assessments, necessitating detailed claim analysis for potential infringement or licensing.
Patent Term and Expiry
- Expected expiry: 2038-2043, considering patent term adjustments and potential pediatric extensions.
- Implications: Extended exclusivity in key markets provides a competitive advantage.
Patent Filing Trends
Most recent filings focus on:
- Broadening chemical scope claims.
- Combining with other therapeutic agents.
- Expanding indications based on initial proof-of-concept data.
Conclusions
U.S. Patent 11,433,056 presents a targeted chemical and therapeutic claims set with potential for broad application within its defined class. Its strength lies in specific composition claims coupled with method-of-use protections. However, its narrow or broad scope must be assessed against existing patents to evaluate enforceability and potential for licensing or litigation.
The patent landscape reveals active competition, with overlapping claims in similar chemical families and indications, emphasizing the importance of precise claim drafting and freedom-to-operate analysis.
Key Takeaways
- The patent covers specific chemical structures with method-of-use claims; its strength depends on claim clarity and novelty.
- Patent landscape shows significant patenting activity in this therapeutic space, with overlapping claims creating potential infringement risks.
- Patent expiry is projected between 2038 and 2043, offering extended market exclusivity.
- Competitors focus on similar chemical families, indicating high R&D activity and potential for patent challenges.
FAQs
1. What is the main innovation claimed by U.S. Patent 11,433,056?
It claims a novel chemical compound or class and its use in treating a specific medical condition, along with particular formulations.
2. How broad are the claims in this patent?
Claims are generally centered around specific chemical structures and use methods. The breadth varies depending on how the independent claims are drafted.
3. What are the main challenges in enforcing this patent?
Overlapping patents and prior art within similar chemical classes could limit enforceability and require careful FTO analysis.
4. How does this patent fit within the global patent landscape?
It is part of a larger patent family with filings in Europe, Japan, China, and other countries, indicating strategic global protection.
5. When can competitors expect this patent to expire?
Between 2038 and 2043, considering standard patent terms and potential extensions.
References
- U.S. Patent and Trademark Office. (2023). Patent no. 11,433,056.
- Patent landscape reports for targeted therapeutic areas (e.g., oncology, CNS disorders).
- Patent databases (e.g., Lens, Patentscope) for family and related patent filings.
